BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34424958)

  • 1. Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
    Chiodin G; Allen JD; Bryant DJ; Rock P; Martino EA; Valle-Argos B; Duriez PJ; Watanabe Y; Henderson I; Blachly JS; McCann KJ; Strefford JC; Packham G; Geijtenbeek TBH; Figdor CG; Wright GW; Staudt LM; Burack R; Bowden TA; Crispin M; Stevenson FK; Forconi F
    Blood; 2021 Oct; 138(17):1570-1582. PubMed ID: 34424958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells.
    Linley A; Krysov S; Ponzoni M; Johnson PW; Packham G; Stevenson FK
    Blood; 2015 Oct; 126(16):1902-10. PubMed ID: 26194765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essential microenvironmental role of oligomannoses specifically inserted into the antigen-binding sites of lymphoma cells.
    Stevenson FK; Forconi F
    Blood; 2024 Mar; 143(12):1091-1100. PubMed ID: 37992212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting.
    Hollander N; Haimovich J
    Front Immunol; 2017; 8():912. PubMed ID: 28824637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma.
    Pfeifer M; Grau M; Lenze D; Wenzel SS; Wolf A; Wollert-Wulf B; Dietze K; Nogai H; Storek B; Madle H; Dörken B; Janz M; Dirnhofer S; Lenz P; Hummel M; Tzankov A; Lenz G
    Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12420-5. PubMed ID: 23840064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.
    Amin R; Mourcin F; Uhel F; Pangault C; Ruminy P; Dupré L; Guirriec M; Marchand T; Fest T; Lamy T; Tarte K
    Blood; 2015 Oct; 126(16):1911-20. PubMed ID: 26272216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.
    Coelho V; Krysov S; Ghaemmaghami AM; Emara M; Potter KN; Johnson P; Packham G; Martinez-Pomares L; Stevenson FK
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18587-92. PubMed ID: 20937880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans.
    Yabe R; Tateno H; Hirabayashi J
    FEBS J; 2010 Oct; 277(19):4010-26. PubMed ID: 20840590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.
    Radcliffe CM; Arnold JN; Suter DM; Wormald MR; Harvey DJ; Royle L; Mimura Y; Kimura Y; Sim RB; Inogès S; Rodriguez-Calvillo M; Zabalegui N; de Cerio AL; Potter KN; Mockridge CI; Dwek RA; Bendandi M; Rudd PM; Stevenson FK
    J Biol Chem; 2007 Mar; 282(10):7405-15. PubMed ID: 17197448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR evidence for oligosaccharide release from the dendritic-cell specific intercellular adhesion molecule 3-grabbing non-integrin-related (CLEC4M) carbohydrate recognition domain at low pH.
    Probert F; Mitchell DA; Dixon AM
    FEBS J; 2014 Aug; 281(16):3739-50. PubMed ID: 24976257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.
    Valle-Argos B; Chiodin G; Bryant DJ; Taylor J; Lemm E; Duriez PJ; Rock PJ; Strefford JC; Forconi F; Burack RW; Packham G; Stevenson FK
    Sci Rep; 2021 Jun; 11(1):11676. PubMed ID: 34083646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
    J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
    J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin).
    Davis CW; Mattei LM; Nguyen HY; Ansarah-Sobrinho C; Doms RW; Pierson TC
    J Biol Chem; 2006 Dec; 281(48):37183-94. PubMed ID: 17001080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins.
    Leclaire C; Lecointe K; Gunning PA; Tribolo S; Kavanaugh DW; Wittmann A; Latousakis D; MacKenzie DA; Kawasaki N; Juge N
    FASEB J; 2018 Jun; 32(6):3301-3320. PubMed ID: 29401627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation and stability of DC-SIGN microdomains require its extracellular moiety.
    Liu P; Wang X; Itano MS; Neumann AK; Jacobson K; Thompson NL
    Traffic; 2012 May; 13(5):715-26. PubMed ID: 22292921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlating Glycoforms of DC-SIGN with Stability Using a Combination of Enzymatic Digestion and Ion Mobility Mass Spectrometry.
    Yen HY; Liko I; Gault J; Wu D; Struwe WB; Robinson CV
    Angew Chem Int Ed Engl; 2020 Sep; 59(36):15560-15564. PubMed ID: 33462887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.